Role of Toll-like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome

Toll-Like Receptor 4 Mutation Protects Obese Mice Against Endothelial Dysfunction by Decreasing NADPH Oxidase Isoforms 1 and 4

(2013) Chao-Fan Liang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity

(2013) Hongxiang Xie et al.   BRITISH JOURNAL OF HAEMATOLOGY

Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells

(2012) Emily Charrier et al.   CELLULAR IMMUNOLOGY

Epoxyeicosatrienoic Acids Contribute With Altered Nitric Oxide and Endothelin-1 Pathways to Conduit Artery Endothelial Dysfunction in Essential Hypertension

(2012) Jeremy Bellien et al.   CIRCULATION

Anti-β2GPI/β2GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways

(2012) Hongxiang Xie et al.   MOLECULAR IMMUNOLOGY

A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome

(2012) Gerd Gladigau et al.   PLoS One

Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells

(2012) Hong Zhou et al.   THROMBOSIS RESEARCH

Immunosuppressant Regimen Based on Sirolimus Decreases Aortic Stiffness in Renal Transplant Recipients in Comparison to Cyclosporine

(2011) R. Joannidès et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

(2011) Olivier Benveniste et al.   ARTHRITIS AND RHEUMATISM

High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: ‘PROS’ and ‘CONS’

(2011) Vittorio Pengo et al.   AUTOIMMUNITY REVIEWS

A novel pathway for human endothelial cell activation by antiphospholipid/anti- 2 glycoprotein I antibodies

(2011) K. L. Allen et al.   BLOOD

Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies

(2011) N. Satta et al.   BLOOD

 2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model

(2011) A. Arad et al.   BLOOD

Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure

(2011) Sébastien Banquet et al.   CIRCULATION

Hypertrophic remodeling and increased arterial stiffness in patients with intracranial aneurysms

(2010) David Maltete et al.   ATHEROSCLEROSIS

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

(2010) M. R. Dasu et al.   DIABETES CARE

Antiphospholipid antibodies promote leukocyte–endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2

(2010) Sangeetha Ramesh et al.   JOURNAL OF CLINICAL INVESTIGATION

Clinical Relevance of Nitric Oxide Metabolites and Nitrative Stress in Thrombotic Primary Antiphospholipid Syndrome

(2010) P. R. J. AMES et al.   JOURNAL OF RHEUMATOLOGY

Antiphospholipid syndrome

(2010) Guillermo Ruiz-Irastorza et al.   LANCET

Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice

(2009) Ygal Benhamou et al.   CRITICAL CARE MEDICINE

The role of Toll-like receptors in chronic inflammation

(2009) Stefan K. Drexler et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

(2009) Marietta Charakida   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patients with antiphospholipid syndrome display endothelial perturbation

(2009) Massimo Cugno et al.   JOURNAL OF AUTOIMMUNITY

Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state

(2009) Jakub Swadzba et al.   RHEUMATOLOGY INTERNATIONAL

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

(2008) R Cervera et al.   ANNALS OF THE RHEUMATIC DISEASES

Hughes Syndrome (the antiphospholipid syndrome)

(2008) Graham R.V. Hughes   AUTOIMMUNITY REVIEWS

Antiphospholipid Antibodies and Atherosclerosis: Insights from Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome

(2008) Paul R. J. Ames et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?

(2008) C Belizna et al.   LUPUS

Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function

(2008) P. Gresele et al.   THROMBOSIS RESEARCH

Early Atheroma in Primary and Secondary Antiphospholipid Syndrome: An Intrinsic Finding

(2007) Cristina C. Belizna et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM